Samsung Biologics reports second quarter 2025 financial results
"Our second quarter results demonstrate continued strong momentum across our business," said John Rim, CEO and President of Samsung Biologics. "With Plant 5 now fully operational, we are leveraging our manufacturing expertise and expanded capacity to deliver seamless, end-to-end CDMO services at scale. We have broadened our portfolio with advancements in antibody-drug conjugates (ADCs) and the launch of research services, Samsung Organoids, further reinforcing our ability to offer a wider range of innovative solutions to clients. Additionally, we are redefining digitalization in biomanufacturing, harnessing advanced digital tools to deliver greater transparency, speed, and value—setting new standards in the industry. These strategic initiatives will continue to strengthen our ability to accelerate client pipelines, while fostering enduring partnerships grounded in quality and operational excellence."
SECOND QUARTER 2025 RESULTS
Samsung Biologics posted consolidated revenue of KRW 1,289.9 billion and operating profit of KRW 475.6 billion in the second quarter of 2025. On a standalone basis, the company reported revenue of KRW 1,014.2 billion and operating profit of KRW 477.0 billion. The growth was buoyed by the full utilization of Plants 1 through 3 and the continued ramp-up of Plant 4.
In the first half of 2025, standalone revenue surpassed KRW 2 trillion, reflecting consistent momentum across all manufacturing plants. Sales contract volume in the first half reached USD 2.4 billion, bringing up the cumulative value to USD 18.7 billion.
BUSINESS UPDATES
In April, Samsung Biologics added 180 kL of capacity with Plant 5 to better meet clients' manufacturing needs. The facility, equipped with advanced automation and digital systems, integrates best practices and features from existing plants to ensure consistent operations and the highest quality standards.
The company also broadened its service offering with the launch of research services, Samsung Organoids, which utilizes patient-derived organoids to support drug discovery and development. Samsung Organoids enables precision screening to predict patient-specific drug responses and provides clients with multi-modal insights to effectively support early-stage decision making.
In May, Samsung Biologics announced plans to spin off its wholly-owned subsidiary, Samsung Bioepis. Through the financial and legal separation, the company will focus on strengthening its core capabilities as a pure-play CDMO, enhancing customer satisfaction and proactively responding to the industry's greater demands to ultimately maximize corporate value and sustainable growth potential.
On the sustainability front, the company released its 2025 ESG report in June, outlining progress in areas including enhanced disclosure standards, an accelerated path to net-zero, and TNFD-aligned risk management. As part of its decarbonization efforts, Samsung Biologics achieved a 24% reduction in greenhouse gas emissions in 2024 compared to the previous year and increased its renewable energy use to 29% of total electricity consumption. The company also signed an additional solar Power Purchase Agreement to further support its energy transition. Beyond operations, Samsung Biologics is actively engaged in collaborative efforts through the Sustainable Market Initiative to decarbonize healthcare supply chains and promote global environmental responsibility.
About Samsung Biologics
Samsung Biologics (KRX: 207940.KS) is a leading contract development and manufacturing organization (CDMO), offering end-to-end integrated services that range from late discovery to commercial manufacturing.
With a combined biomanufacturing capacity of 784 kL across five plants, Samsung Biologics leverages cutting-edge technologies and expertise to advance diverse modalities, including multispecific antibodies, fusion proteins, antibody-drug conjugates, and mRNA therapeutics.
Samsung Biologics operates a global network with facilities and offices in Korea, the U.S., and Japan. Samsung Biologics America supports clients based in the U.S. and Europe, while its Tokyo sales office serves the APAC region.
Samsung Biologics continues to invest in new capabilities to maximize operational and quality excellence, ensuring flexibility and agility for clients. The company is committed to the on-time, in-full delivery of safe, high-quality products, as well as making sustainable business decisions for the betterment of society and global health.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Korea Herald
an hour ago
- Korea Herald
Xinhua Silk Road: Weihai tops Shandong in ecological environment quality for three consecutive years
BEIJING, July 28, 2025 /PRNewswire/ -- Weihai, a coastal city in east China's Shandong Province, has maintained its leading position in ecological environment quality across the province for the third consecutive year, demonstrating its firm commitment to green development. In 2024, it topped Shandong in both overall ambient air quality and improvement rate, with key indicators, such as PM2.5 and PM10 concentrations, and excellent air quality days, all showing strong performance. Water quality indicators were equally impressive. All 13 key rivers and 12 urban centralized drinking water sources met required standards. Soil remediation efforts also yielded consistent results. The city also maintained a 100 percent safe utilization rate for contaminated farmland and key construction land for five straight years. Weihai continues to deepen its pollution control efforts through comprehensive initiatives targeting blue skies, clean waters, and coastal ecosystems. As a national pilot city for advancing climate adaptation, Weihai established a dedicated working group and actively advancing the modernization of its climate governance, said Wang Xihai, a researcher at the Weihai Municipal Ecology and Environment Bureau. Currently, the city's four Eco-environment Oriented Development (EOD) projects, with a total investment of 6.4 billion yuan, have been included in the provincial green finance project pool. Looking ahead, Weihai plans to roll out additional EOD projects, aiming to further align high-level environmental protection with high-quality economic growth.
Korea Herald
2 hours ago
- Korea Herald
JBO Thailand Launches Esports World Cup Promotion with Rewards Up to 30,000 Jcoin
BANGKOK, July 28, 2025 /PRNewswire/ -- JBO, a well-established online gaming and entertainment platform, is pleased to announce an exciting new promotion tailored for the highly anticipated Esports World Cup 2025. Esports enthusiasts in Thailand now have a compelling opportunity to win up to 30,000 Jcoin by placing wagers on the thrilling "World Cup Qualifiers" matches. This shows JBO Thailand's commitment to giving great value and fun experiences to all its players. This exclusive event is ongoing and will conclude on August 24, 2025, at 23:59 (GMT+8). This period strategically aligns with the intensified global esports calendar, leading up to the Esports World Cup and its critical qualifying rounds. JBO Thailand is actively creating an immersive environment that allows fans to engage more deeply with preferred teams and competitive events. Participation in the promotion is straightforward. Players are simply required to place bets on eligible "Esports World Cup Qualifiers" matches through JBO's designated esports betting providers, IM Esports and TF Esports. The promotion is conveniently accessible via the "Reward Corner" section on the JBO platform, ensuring a seamless and intuitive user experience for all participants. At the core of this attractive offer is JBO's innovative Jcoin reward system. Players who log in to JBO and achieve a weekly turnover exceeding 3,000 in the Esports category will automatically qualify for Jcoin rewards. The reward system gives bigger prizes as you play more, with up to 30,000 Jcoin available each week. JBO also ensures a smooth and secure experience through the easy-to-use JBO app available for both Android and iOS devices. With fast withdrawals and smooth gameplay, the platform is ideal for esports fans to enjoy and earn real rewards. JBO is trusted across Asia and has Dimitar Berbatov as its brand ambassador, showing it as a top sportsbook and esports operator. JBO or Just Bet Online, is a trusted online gaming website that started in 2019 catering Thailand users. Players can bet on popular games like DOTA 2, CS:GO, and ROV, or enjoy fun slot machines and real-time casino tables. It also hosts fun events such as the JBO Thailand Super Cup engaging football fans.
Korea Herald
a day ago
- Korea Herald
5th China New E-commerce Conference Opens in Yanbian, Jilin Province
YANJI, China, July 27, 2025 /PRNewswire/ -- This is a news release from The 5th China New E-commerce Conference opened today in Yanbian, Jilin Province, aiming to deepen public-private dialogue and drive the continued evolution of the country's digital commerce sector. The event is hosted by the China Federation of Internet Societies and co-organized by the China International Electronic Commerce Center, the Publicity Department of the CPC Jilin Provincial Committee, the Cyberspace Administration of Jilin Province, the Jilin Provincial Department of Commerce, and the People's Government of Yanbian Korean Autonomous Prefecture, with additional support from the China Chamber of International Commerce. Positioned as a high-level platform for engagement between government regulators and industry leaders, the conference reflects the growing role of emerging e-commerce platforms in shaping digital innovation and corporate social responsibility. It also highlights efforts to promote regional alignment, resource integration, and sustainable digital economic growth. Held under the theme "A New Era of Digital intelligence, A New Value for E-commerce," the program features an opening ceremony, main forum, sub-forums, specialized breakout sessions, and a series of satellite events. Among the highlights were policy briefings and keynote addresses from senior government officials and industry executives, the release of the China New E-commerce Development Report (2025), and the presentation of new case studies documenting innovation across the e-commerce sector. Organizers also introduced the fourth cohort of top-performing livestream hosts as part of the ongoing Talent Development Program and formally launched the Empowering Premium Hosts Initiative. The event additionally marked the rollout of two new initiatives: the Integrated Cross-border Exhibition and Sales Project and the High-quality Development Campaign for New E-commerce. Four thematic sub-forums focused on technological innovation, integrated development, cross-border e-commerce, and sustainability and corporate responsibility. Two featured events—the industry chain matchmaking and exhibition showcase, and a dedicated session on the ginseng industry—offered insight into key regional and vertical strengths. In parallel, a slate of related activities was held, including the High-quality Development Campaign for New E-commerce, the national finals of the China E-commerce Host Competition—which emphasized revitalization efforts in China's border regions through health and wellness—and continued programming under the Empowering Premium Hosts Initiative. Collectively, these efforts aim to translate the conference's agenda into practical outcomes and unlock further growth across the broader e-commerce ecosystem.
